info@fortunebiosciences.com

  •  2 In 1 (cTnI/CK-MB) Reagent Kit (Quantitative)
 2 In 1 (cTnI/CK-MB) Reagent Kit (Quantitative)

2 In 1 (cTnI/CK-MB) Reagent Kit (Quantitative)

  • Product description: POCT Reagent Kit, clinical diagnostic reagent, clinical chemistry reagent, clinical diagnostic testing, biochemistry test kit, Fluorescence Immunoassay Analyzer, POCT Analyzer, FIA, POCT
  • INQUIRY
Details

Product Name: 2 In 1 (cTnI/CK-MB) Reagent Kit (Quantitative)

Method: Lateral-Flow technology (Fluorescent Immunochromatographic

Product Models: 5 tests/box, 25 tests/box, 40 tests/box, 100 tests/box

CFDA Registration No.: 20152400173

Certification: CE, SGS ISO13485, ISO9001

Matching Equipment's: Solid Phase Fluorescence Immunoassay System (KOFA Brand). 

Introduction: This reagent kit is base on fluorescent chromatographic technology, supporting the quantitative rapid test of cTnI/CK-MB level in the serum/plasma. The combined testing of cTnI/CK-MB is used to diagnose myocardial injury and infarction.

cTnI/CK-MB Technical Parameters:

Test Item Sample Reacting Time Testing Time
cTnI/CK-MB Plasma/Serum/Whole Blood:75μL 15min 3S

The advantages of 2 In 1 (cTnI/ CK-MB):

1. Advanced fluoroimmunoassay quantitative testing platform, make accurate and quantitative rapid test of cTnI/CK-MB level available

2. Low cost and rapid test, can get the quantitative and reliable results in 15 minutes, shorten the testing turnaround time.

3. The testing results of this cTnI/CK-MB kit have good correlation with that of Roche Diagnostics (compared with thousands of samples).

4. Simple operation and rapid test, can meet the need of various departments.

5. The combined testing of cTnI and CK-MB is more convenient, accurate and efficient than single testing items, making the patients well-treated in the shorter time.

Applicable Departments: Departments of cardiology, surgery, geriatrics, respiratory, pediatrics, obstetrics, emergency ward and ICU.

Scan the qr codeClose
the qr code